Clinical Validation for Software and AI Medical Devices
Bioexcel supports SaMD, digital health and AI-enabled technologies with clinical validation strategy, prospective and retrospective studies, dataset assessment, algorithm performance analysis, subgroup analysis, human factors, biostatistics and regulatory documentation.
Our approach focuses on whether the software performs as intended in the right population, clinical environment and real-world workflow.
Does Bioexcel Support Clinical Validation of SaMD and AI Medical Devices?
Yes. Bioexcel supports clinical validation of SaMD and AI-enabled medical devices through intended-use analysis, study design, dataset assessment, clinical performance evaluation, subgroup analysis, biostatistics, human factors, real-world evidence and regulatory medical writing.
Bioexcel Lifesciences & Research LLP supports clinical validation of SaMD, digital health and AI-enabled medical devices through study design, dataset strategy, clinical performance analysis, subgroup assessment, biostatistics, human factors, post-market evidence and regulatory medical writing.
The Question Is Not Only “Is the Algorithm Accurate?”
Clinical validation should address questions such as:
- Does the software work in the intended population?
- Does it perform across clinically relevant subgroups?
- Is the comparator/reference standard appropriate?
- Does performance remain clinically meaningful?
- Can the user correctly interpret the output?
- Does the software fit the clinical workflow?
- Is the tested software version the same as the intended product?
- Are limitations understood?
- Is the benefit-risk profile supported?
A high technical accuracy score alone does not establish complete clinical validity.
From Intended Use to Regulatory Evidence
Intended Use
- Clinical purpose
- User
- Patient population
- Care setting
- Software output
Output: Clinical Use Case
Clinical Question
- Diagnosis
- Prediction
- Classification
- Triage
- Monitoring
- Decision support
Output: Validation Objective
Reference Standard
- Expert diagnosis
- Laboratory result
- Imaging interpretation
- Clinical outcome
- Adjudication panel
Output: Reference Framework
Dataset / Study Design
- Retrospective validation
- Prospective validation
- Hybrid design
- External validation
Output: Validation Strategy
Software Version Control
- Algorithm version
- Model version
- Software build
- Locked vs adaptive behavior
Output: Version Traceability
Data Collection
- Inputs
- Reference result
- Algorithm output
- Clinical metadata
- Subgroups
Output: Clinical Validation Dataset
Statistical Analysis
- Performance
- Confidence intervals
- Subgroups
- Bias
- Calibration where appropriate
Output: Performance Results
Clinical Interpretation
- Clinical relevance
- Limitations
- Workflow impact
- Generalizability
Output: Clinical Conclusion
Lifecycle Evidence
- Clinical evaluation
- Risk Management
- PMS
- PMCF
- Software change strategy
Output: Regulatory Evidence
What Is Clinical Validation of an AI Medical Device?
Clinical validation of an AI medical device is the evaluation of whether the software produces clinically meaningful and reliable outputs in its intended patient population, intended use environment and clinical workflow using an appropriate reference standard and predefined performance criteria.
What AI/SaMD validation services does Bioexcel provide?
Bioexcel supports clinical validation strategy, retrospective and prospective validation, dataset assessment, reference-standard planning, algorithm performance analysis, subgroup analysis, biostatistics, human factors, real-world evidence and regulatory medical writing for AI-enabled medical devices and SaMD.
Can Bioexcel support both clinical and statistical validation?
Yes. Bioexcel can connect clinical study design and data acquisition with statistical performance analysis and clinical interpretation.
Can Bioexcel support post-market AI evidence?
Yes. Bioexcel can support real-world performance monitoring, PMCF strategies and clinical evaluation updates for AI and software medical devices.
Validation Starts With a Precise Clinical Use Case
Intended Purpose
What does the software do?
Intended User
Who uses it?
Intended Population
Which patients?
Intended Setting
Output
If the intended use is unclear, the validation strategy will also be unclear.
Why Is Intended Use Important in AI Clinical Validation?
The intended use defines the target population, user, clinical setting, software output and clinical decision that the AI is intended to support. These elements determine the appropriate dataset, comparator, endpoints and performance criteria for validation.
Define Exactly What the AI Is Being Asked to Do
Diagnostic
Detect disease.
Classification
Assign category or severity.
Prediction
Estimate future clinical risk.
Triage
Prioritize patients.
Quantification
Measure anatomical or physiological features.
Monitoring
Track clinical change over time.
Each requires a different validation design.
The Algorithm Is Only as Meaningfully Validated as the Comparator
Potential reference standards:
- Pathology
- PCR
- Laboratory result
- Expert radiologist interpretation
- Specialist diagnosis
- Clinical outcome
- Adjudication committee
- Established gold standard
The Comparator Should Be
Clinical Validation for Radiology and Imaging Algorithms
- Expert reader reference
- Multi-reader assessment
- Imaging modality
- Acquisition variability
- Image quality
- Scanner diversity
- Reader variability
- Patient subgroup
Can Bioexcel Support Imaging AI Clinical Validation?
Yes. Bioexcel can support imaging AI validation strategies involving appropriate clinical datasets, expert-reference methods, predefined endpoints, subgroup analysis and statistical performance evaluation.
Existing Clinical Data Can Support Validation When Fit for Purpose
Potential sources:
- Hospital records
- Imaging archives
- Laboratory databases
- Existing clinical datasets
- Biobank-linked data
Assess
Can Bioexcel Validate an AI Medical Device Using Retrospective Data?
Potentially yes. Bioexcel can support retrospective clinical validation when the dataset is sufficiently representative, reliable, appropriately labeled, traceable and suitable for the intended clinical validation objective.
Validate Performance in Real Clinical Workflow
Prospective studies can evaluate:
- Real-time input
- Clinical workflow
- User interaction
- Processing time
- Algorithm output
- Reference result
- Clinical decision impact
Potential Advantages
Testing on Data Independent From Development
External validation can help assess:
- Generalizability
- Population differences
- Site differences
- Scanner/device differences
- Clinical-practice variation
A model performing well in its development dataset may perform differently elsewhere.
Keep Development and Validation Conceptually Separate
Training Data
Used to develop the algorithm.
Tuning / Validation Data
May support model optimization.
Independent Clinical Validation Data
Used to assess final clinical performance.
The website should clearly explain that independent evaluation strengthens confidence in performance.
Know Where Every Clinical Data Point Came From
Validation should document:
- Data source
- Site
- Date range
- Population
- Data collection method
- Reference label
- Data processing
- Inclusion/exclusion
- Missing data
Does the Dataset Reflect the Intended Population?
Assess:
- Age
- Sex
- Disease severity
- Comorbidities
- Ethnicity where relevant and legally/ethically appropriate
- Geography
- Clinical site
- Disease prevalence
- Device/scanner type
- Clinical setting
A model may show strong average performance while underperforming in a clinically important subgroup.
Why Is Data Provenance Important for AI Medical Devices?
Data provenance helps establish where validation data originated, how they were collected and labeled, which patients were included and whether the dataset is appropriate and traceable for the intended clinical validation.
Look Beyond Overall Accuracy
Potential subgroups:
- Age
- Sex
- Disease stage
- Comorbidity
- Site
- Geography
- Scanner
- Device type
- Clinical setting
- User type
Can Bioexcel Perform Subgroup Analysis for AI Medical Devices?
Yes. Bioexcel can support predefined subgroup analyses to assess whether clinical performance remains consistent across relevant patient, site, device and workflow characteristics.
Clinical Bias Can Appear in Different Ways
Potential sources:
- Dataset selection
- Missing populations
- Labeling
- Site concentration
- Scanner/device concentration
- Disease prevalence
- Reference-standard differences
Bioexcel Can Support Assessment Through
How Can Bias Be Assessed in Medical AI Validation?
Bias can be assessed by evaluating dataset representativeness, subgroup performance, site-level variability, reference-label quality, missing data and systematic differences in performance across clinically relevant populations or settings.
Common Performance Measures
Depending on the use case:
Performance metrics should reflect the clinical consequence of errors.
Useful for Some Classification Algorithms
AUROC alone may not be sufficient to establish clinical utility.
Confusion Matrix
| Reference Positive | Reference Negative | |
|---|---|---|
| AI Positive | True Positive | False Positive |
| AI Negative | False Negative | True Negative |
Choice of measures should be clinically justified.
Prediction Models Need More Than Discrimination
For risk-prediction models, validation may consider:
- Observed vs predicted risk
- Calibration plot
- Calibration slope/intercept
- Brier score where appropriate
A model can discriminate between patients while still systematically over- or underestimating actual risk.
Does the Output Help Clinical Decision-Making?
Potential questions:
- Does it improve detection?
- Does it reduce missed cases?
- Does it improve triage?
- Does it reduce interpretation time?
- Does it change management?
- Does it create unnecessary interventions?
Technical performance and clinical utility are related but not identical.
Validate the User, Not Just the Algorithm
Assess:
- Can users understand the output?
- Is uncertainty clear?
- Do users over-rely on the AI?
- Can users override recommendations?
- Are alerts understandable?
- Is the workflow practical?
This is especially important for decision-support systems.
Digital Clinical Evidence Includes User Interaction
Bioexcel can support human factors / usability evidence relating to:
- Interface
- Navigation
- Alerts
- Instructions
- Result interpretation
- User errors
- Critical tasks
- Clinical workflow
Which Algorithm Was Actually Validated?
Document:
- Software version
- Model version
- Build number
- Release date
- Validation configuration
- Locked parameters
- Thresholds
- Post-validation changes
Why Is Software Version Traceability Important?
Software version traceability establishes which exact algorithm and software configuration generated the clinical validation results and helps determine whether later software changes could affect the applicability of that evidence.
Clinical Evidence Strategy Depends on How the Algorithm Changes
Locked Algorithm
Performance remains fixed unless a controlled software update occurs.
Adaptive Algorithm
May change based on new data or predefined update mechanisms.
The evidence and change-management strategy should account for how the software evolves.
A New Version May Need Impact Assessment
Assess whether changes affect:
- Intended use
- Algorithm
- Input data
- Output
- Threshold
- User interface
- Clinical workflow
- Performance
Potential Outcomes
Avoid Artificially Inflated Performance
Potential leakage can occur if:
- Same patient appears in development and validation datasets
- Related images are split across datasets
- Future information influences labels
- Model indirectly sees the reference outcome
Validation design should minimize these risks.
Does Performance Change Across Hospitals?
- Overall performance
- Site-specific performance
- Heterogeneity
- Scanner/device differences
- Workflow differences
Multi-site external validation can strengthen generalizability.
Sample Size Should Reflect the Clinical Performance Objective
Potential inputs:
- Expected sensitivity
- Expected specificity
- Precision
- Confidence level
- Disease prevalence
- Positive/negative cohort requirements
- Subgroup needs
- Invalid/excluded data
Can Bioexcel Calculate Sample Size for AI Clinical Validation?
Yes. Bioexcel can support sample-size planning based on the intended clinical performance metrics, precision, confidence intervals, prevalence or cohort structure, subgroup requirements and expected non-evaluable data.
Document the Validation Before Running the Analysis
Potential protocol content:
- Intended use
- Target population
- Dataset
- Reference standard
- Endpoints
- Inclusion/exclusion
- Algorithm version
- Blinding
- Data processing
- Statistical analysis
- Subgroups
- Missing data
- Bias assessment
Avoid Influencing the Reference Standard or AI Result
Where appropriate:
- Reference reviewers should not know AI output.
- AI output should not influence reference labeling.
- Adjudication rules should be predefined.
This reduces bias in diagnostic-performance evaluation.
Clinical AI Validation Requires Controlled Data Handling
Bioexcel can support:
- Dataset specification
- eCRF
- EDC
- Data matching
- Reference-result capture
- Algorithm-result capture
- Query management
- Database lock
Statistical Analysis of AI Clinical Performance
Potential methods:
- Sensitivity
- Specificity
- PPA/NPA
- ROC/AUROC
- Confidence intervals
- Calibration
- Subgroup analysis
- Site-level analysis
- Sensitivity analysis
From Validation Data to Clinical Evidence Documentation
Bioexcel can support:
- Validation protocol
- Clinical study report
- Clinical evaluation documentation
- Performance evidence summary
- PMCF/PMS content
- Regulatory response
AI Clinical Evidence Should Fit the Full Clinical Argument
Potential inputs:
- Intended purpose
- Clinical claims
- Validation data
- Literature
- State of the art
- Risk Management
- PMS
- PMCF
- Software changes
Performance May Change After Deployment
Post-market monitoring may assess:
- Clinical performance
- User behavior
- Population drift
- Input-data drift
- Error patterns
- False positive/negative trends
- Software complaints
- Clinical incidents
Future Data May Differ From Validation Data
Changes can occur in:
- Patient population
- Disease prevalence
- Scanner/device
- Clinical practice
- Workflow
- Data quality
Monitoring can help identify when performance reassessment may be needed.
Post-Market Clinical Evidence for Software
Potential PMCF methods:
- Prospective performance monitoring
- Registry
- Real-world evidence
- Targeted clinical study
- User feedback
- Literature
- Version-specific validation
The appropriate strategy depends on the residual clinical evidence questions.
AI-Enabled Diagnostics
Imaging Algorithms Need Diverse Clinical Validation
Consider:
- Modality
- Scanner manufacturer
- Image acquisition
- Clinical site
- Patient population
- Reader reference
- Disease severity
- Image quality
Multi-site external datasets may be valuable where feasible.
Validation Beyond Diagnosis
For remote patient monitoring, potential endpoints include:
- Measurement agreement
- Alert accuracy
- Data completeness
- Adherence
- Clinical response
- Usability
- Device connectivity
Clinical Validation in India
India may support:
- Retrospective hospital datasets
- Prospective clinical validation
- Imaging datasets
- Diagnostic populations
- User studies
Can Bioexcel Conduct AI Medical Device Validation in India?
Bioexcel can support suitable AI and SaMD clinical validation programs in India using appropriate clinical sites and datasets, subject to the intended use, study design, data governance and applicable regulatory requirements.
European Clinical Validation Programs
European programs may require consideration of:
- Site suitability
- Intended population
- GDPR
- Data governance
- Cross-border data flows
- Software/device regulation
- Ethics
Bioexcel can support through suitable local resources combined with centralized data and biostatistical expertise.
Different Populations Can Strengthen Generalizability
India Data
- Development-independent validation
- Larger clinical populations
- Selected diagnostic cohorts
Europe Data
- European target population
- Local clinical workflow
- External validation
However, geographic pooling should only be used where scientifically appropriate.
Already Have a Validation Dataset?
Bioexcel can assess:
- Dataset structure
- Population
- Reference labels
- Missing data
- Data provenance
- Subgroups
- Statistical suitability
- Validation independence
Can Bioexcel Review an Existing AI Validation Dataset?
Yes. Bioexcel can assess whether an existing dataset is suitable for the proposed clinical validation objective and identify gaps involving population coverage, labels, data quality, subgroup representation and statistical analysis.
Strong Algorithm, Weak Evidence Package?
Potential problems:
- Only internal validation
- No independent dataset
- Weak comparator
- Unclear intended population
- No subgroup analysis
- No confidence intervals
- Uncontrolled software version
- Dataset leakage concerns
Why MedTech Innovators Use Bioexcel for AI & SaMD Clinical Validation
Medical Device + Data Perspective
The study is built around clinical and regulatory use, not only model metrics.
Clinical Population Focus
Performance is assessed in relevant intended users and patients.
Biostatistics Integration
Sensitivity, specificity, AUROC, calibration and subgroup analyses are planned prospectively.
Data Management
Clinical datasets, reference labels and algorithm outputs can be centrally structured.
Real-World Evidence
Post-market performance can be monitored over time.
Full-Service or Functional Support
Sponsors can outsource one component or the complete clinical evidence program.
AI / SaMD Clinical Validation Deliverables
Depending on scope:
- AI/SaMD Clinical Evidence Gap Assessment
- Clinical validation strategy
- Dataset feasibility assessment
- Dataset specification
- Clinical validation protocol
- Reference-standard strategy
- Endpoint framework
- Sample-size calculation
- Statistical Analysis Plan
- Subgroup analysis plan
- Bias assessment
- Data Management Plan
- eCRF / EDC
- Statistical outputs
- Clinical validation report
- Clinical evaluation input
- PMCF strategy
- PMS/RWE analysis
- Regulatory response support
AI Clinical Validation in Practice
Diagnostic Classification Algorithm
Clinical Question: Detect target disease
Reference: Established clinical reference method — Analysis: Sensitivity, specificity, confidence intervals and subgroups
Imaging AI
Clinical Question: Detect radiological abnormality
Validation: Independent multi-site image dataset — Analysis: Overall + subgroup + site performance
Predictive SaMD
Clinical Question: Estimate patient risk
Analysis: Discrimination + calibration + subgroup assessment
Frequently Asked Questions About AI & SaMD Clinical Validation
Yes. Bioexcel supports clinical validation of AI-enabled medical devices and SaMD through study design, datasets, performance analysis, subgroup assessment, statistics and clinical reporting.
Bioexcel validates AI and SaMD in the clinical context in which the software is intended to influence healthcare decisions.